2/3
08:03 am
tbph
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $40.00 price target on the stock.
2/3
07:09 am
tbph
Rating for TBPH
Low
Report
Rating for TBPH
12/3
11:29 am
tbph
Rating for TBPH
Low
Report
Rating for TBPH
12/3
11:29 am
tbph
Rating for TBPH
Low
Report
Rating for TBPH
12/3
07:02 am
tbph
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Low
Report
Theravance Biopharma (NASDAQ:TBPH) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
12/3
06:16 am
tbph
Theravance Biopharma initiated with an Outperform at Oppenheimer
High
Report
Theravance Biopharma initiated with an Outperform at Oppenheimer
12/3
06:16 am
tbph
Theravance Biopharma initiated with an Outperform at Oppenheimer
High
Report
Theravance Biopharma initiated with an Outperform at Oppenheimer
11/26
07:08 am
tbph
Rating for TBPH
Medium
Report
Rating for TBPH